ATRenew (NYSE: RERE) grants Wang Yongliang seven stock option awards

Q: What insider transaction did ATRenew Inc. (RERE) report for Wang Yongliang?

ATRenew Inc. reported that Wang Yongliang received multiple option grants on 2026-08-18. These options are compensation-style awards giving him rights to acquire Class A ordinary shares at a fixed exercise price in future years.

Q: When can the newly granted ATRenew Inc. (RERE) options to Wang Yongliang be exercised?

The options have exercise dates ranging from 2025-07-01 to 2027-04-01 . After each respective exercise date, the corresponding option block becomes exercisable through its stated expiration date in 2035 or 2036.

Q: What are the expiration dates of the options granted to Wang Yongliang by ATRenew Inc. (RERE)?

The reported option grants expire between 2035-04-01 and 2036-06-29 . Each block of options has its own specific expiration date, after which any unexercised options from that block will no longer be exercisable.

Q: Do the reported ATRenew Inc. (RERE) insider transactions involve any stock sales?

No, the filing reports only acquisitions of options , not stock sales. All seven transactions are coded as grants or awards of derivative securities, with no corresponding dispositions of shares or options disclosed.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

ATRenew Inc. (RERE) reported that Executive President and director Wang Yongliang received several option grants on 2026-08-18. These options give the right to buy Class A ordinary shares at an exercise price of $0.10 per share, with exercise dates ranging from 2025-07-01 to 2027-04-01 and expirations between 2035 and 2036.

Insider Trade Summary

7 transactions reported

Mixed 7 txns

Insider Wang Yongliang

Role Executive President

Type	Security	Shares	Price	Value
Grant/Award	Options (Right to Buy)	12,162	$0.00	$0.00
Grant/Award	Options (Right to Buy)	11,578	$0.00	$0.00
Grant/Award	Options (Right to Buy)	7,847	$0.00	$0.00
Grant/Award	Options (Right to Buy)	76,796	$0.00	$0.00
Grant/Award	Options (Right to Buy)	6,985	$0.00	$0.00
Grant/Award	Options (Right to Buy)	37,975	$0.00	$0.00
Grant/Award	Options (Right to Buy)	5,703	$0.00	$0.00

Holdings After Transaction: Options (Right to Buy) — 159,046 shares (Direct)

Key Figures

Option grant 1 shares: 12,162 options Option grant 2 shares: 11,578 options Option grant 3 shares: 7,847 options +5 more

8 metrics

Option grant 1 shares 12,162 options Options (Right to Buy) granted on 2026-08-18, exercise date 2025-07-01, expiration 2035-07-01

Option grant 2 shares 11,578 options Options granted on 2026-08-18, exercise date 2026-01-01, expiration 2036-01-01

Option grant 3 shares 7,847 options Options granted on 2026-08-18, exercise date 2026-04-01, expiration 2035-04-01

Option grant 4 shares 76,796 options Options granted on 2026-08-18, exercise date 2026-06-03, expiration 2035-06-03

Option grant 5 shares 6,985 options Options granted on 2026-08-18, exercise date 2026-06-29, expiration 2036-06-29

Option grant 6 shares 37,975 options Options granted on 2026-08-18, exercise date 2027-01-01, expiration 2036-01-01

Option grant 7 shares 5,703 options Options granted on 2026-08-18, exercise date 2027-04-01, expiration 2036-04-01

Option exercise price $0.10 per share Conversion or exercise price for each option grant on Class A ordinary shares

Key Terms

Options (Right to Buy), exercise date, expiration date, Class A ordinary shares

4 terms

Options (Right to Buy) financial

"security_title: Options (Right to Buy)"

exercise date financial

"exercise_date: 2025-07-01"

expiration date financial

"expiration_date: 2035-07-01"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

Class A ordinary shares financial

"underlying_security_title: Class A ordinary shares"

Class A ordinary shares are a type of ownership stake in a company that typically grants voting rights to shareholders, allowing them to have a say in important company decisions. They often come with priority in receiving dividends or profits, making them attractive to investors seeking influence and potential income. These shares help distinguish different levels of ownership and rights within a company's stock structure.

FAQ

What insider transaction did ATRenew Inc. (RERE) report for Wang Yongliang?

ATRenew Inc. reported that Wang Yongliang received multiple option grants on 2026-08-18. These options are compensation-style awards giving him rights to acquire Class A ordinary shares at a fixed exercise price in future years.

What is the exercise price of the options granted to Wang Yongliang at ATRenew Inc. (RERE)?

Each option grant to Wang Yongliang carries an exercise price of $0.10 per share. This price applies to the underlying Class A ordinary shares associated with all reported option awards in this filing.

When can the newly granted ATRenew Inc. (RERE) options to Wang Yongliang be exercised?

The options have exercise dates ranging from 2025-07-01 to 2027-04-01. After each respective exercise date, the corresponding option block becomes exercisable through its stated expiration date in 2035 or 2036.

What are the expiration dates of the options granted to Wang Yongliang by ATRenew Inc. (RERE)?

The reported option grants expire between 2035-04-01 and 2036-06-29. Each block of options has its own specific expiration date, after which any unexercised options from that block will no longer be exercisable.

Do the reported ATRenew Inc. (RERE) insider transactions involve any stock sales?

No, the filing reports only acquisitions of options, not stock sales. All seven transactions are coded as grants or awards of derivative securities, with no corresponding dispositions of shares or options disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/20/2026 - 06:16 AM Accepted by SEC EDGAR 08/20/2026 - 06:16 AM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wang Yongliang

(Last)

(First)

(Middle)

12TH FLOOR, NO 6 BUILDING

433 SONGHU ROAD

(Street)

SHANGHAI

200433

(City)

(State)

(Zip)

CHINA

(Country)

2. Issuer Name and Ticker or Trading Symbol
ATRenew Inc. [ RERE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Executive President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Options (Right to Buy)	$0.1	08/18/2026		A		12,162		07/01/2025	07/01/2035	Class A ordinary shares	12,162	$0	12,162	D
Options (Right to Buy)	$0.1	08/18/2026		A		11,578		01/01/2026	01/01/2036	Class A ordinary shares	11,578	$0	11,578	D
Options (Right to Buy)	$0.1	08/18/2026		A		7,847		04/01/2026	04/01/2035	Class A ordinary shares	7,847	$0	7,847	D
Options (Right to Buy)	$0.1	08/18/2026		A		76,796		06/03/2026	06/03/2035	Class A ordinary shares	76,796	$0	76,796	D
Options (Right to Buy)	$0.1	08/18/2026		A		6,985		06/29/2026	06/29/2036	Class A ordinary shares	6,985	$0	6,985	D
Options (Right to Buy)	$0.1	08/18/2026		A		37,975		01/01/2027	01/01/2036	Class A ordinary shares	37,975	$0	37,975	D
Options (Right to Buy)	$0.1	08/18/2026		A		5,703		04/01/2027	04/01/2036	Class A ordinary shares	5,703	$0	5,703	D

Explanation of Responses:

	/s/ Wang Yongliang	08/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR